Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2013, Article ID 183487, 8 pages
http://dx.doi.org/10.1155/2013/183487
Research Article

DNA Damage in Rheumatoid Arthritis: An Age-Dependent Increase in the Lipid Peroxidation-Derived DNA Adduct, Heptanone-Etheno-2′-Deoxycytidine

1Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka 565-0871, Japan
2Research Center for Environmental Quality Management, Kyoto University, 1-2 Yumihama, Otsu, Shiga 520-0811, Japan
3Department of Immunopathology, WPI Immunology Frontier Research Center, Osaka University, 3-1 Yamada-Oka, Suita, Osaka 565-0871, Japan
4Department of Biomedical Statistics, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka 565-0871, Japan
5Department of Clinical Application of Biologics, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka 565-0871, Japan

Received 15 February 2013; Revised 22 July 2013; Accepted 1 September 2013

Academic Editor: Guglielmina Pepe

Copyright © 2013 Masako Ogawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. B. McInnes and G. Schett, “The pathogenesis of rheumatoid arthritis,” The New England Journal of Medicine, vol. 365, no. 23, pp. 2205–2219, 2011. View at Google Scholar · View at Scopus
  2. S. Bashir, G. Harris, M. A. Denman, D. R. Blake, and P. G. Winyard, “Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases,” Annals of the Rheumatic Diseases, vol. 52, no. 9, pp. 659–666, 1993. View at Google Scholar · View at Scopus
  3. Y. Ozkan, S. Yardým-Akaydýn, A. Sepici, E. Keskin, V. Sepici, and B. Simsek, “Oxidative status in rheumatoid arthritis,” Clinical Rheumatology, vol. 26, no. 1, pp. 64–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. C. A. Hitchon and H. S. El-Gabalawy, “Oxidation in rheumatoid arthritis,” Arthritis Research and Therapy, vol. 6, no. 6, pp. 265–278, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Altindag, M. Karakoc, A. Kocyigit, H. Celik, and N. Soran, “Increased DNA damage and oxidative stress in patients with rheumatoid arthritis,” Clinical Biochemistry, vol. 40, no. 3-4, pp. 167–171, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Shao, H. Fujii, I. Colmegna, H. Oishi, J. J. Goronzy, and C. M. Weyand, “Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis,” Journal of Experimental Medicine, vol. 206, no. 6, pp. 1435–1449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. P.-H. Chou, S. Kageyama, S. Matsuda et al., “Detection of lipid peroxidation-induced DNA adducts caused by 4-oxo-2(E)-nonenal and 4-oxo-2(E)-hexenal in human autopsy tissues,” Chemical Research in Toxicology, vol. 23, no. 9, pp. 1442–1448, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Liagre, P. Vergne, M. Rigaud, and J.-L. Beneytout, “Arachidonate 15-lipoxygenase of reticulocyte-type in human rheumatoid arthritis type B synoviocytes and modulation of its activity by proinflammatory cytokines,” The Journal of Rheumatology, vol. 26, no. 5, pp. 1044–1051, 1999. View at Google Scholar · View at Scopus
  9. E. Ferrante, N. Vazzana, F. Santilli et al., “Determinants of thromboxane biosynthesis in rheumatoid arthritis: role of RAGE and oxidant stress,” Free Radical Biology and Medicine, vol. 49, no. 5, pp. 857–864, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Baskol, H. Demir, M. Baskol et al., “Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis,” Cell Biochemistry and Function, vol. 24, no. 4, pp. 307–311, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Google Scholar · View at Scopus
  12. R. A. Kanaly, S. Matsui, T. Hanaoka, and T. Matsuda, “Application of the adductome approach to assess intertissue DNA damage variations in human lung and esophagus,” Mutation Research, vol. 625, no. 1-2, pp. 83–93, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Pollack, T. Oe, S. H. Lee, M. V. S. Elipe, B. H. Arison, and I. A. Blair, “Characterization of 2′-deoxycytidine adducts derived from 4-oxo-2-nonenal, a novel lipid peroxidation product,” Chemical Research in Toxicology, vol. 16, no. 7, pp. 893–900, 2003. View at Google Scholar · View at Scopus
  14. I. A. Blair, “DNA adducts with lipid peroxidation products,” The Journal of Biological Chemistry, vol. 283, no. 23, pp. 15545–15549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Seven, S. Güzel, M. Aslan, and V. Hamuryudan, “Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis,” Clinical Biochemistry, vol. 41, no. 7-8, pp. 538–543, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. P. I. Mapp, M. C. Grootveld, and D. R. Blake, “Hypoxia, oxidative stress and rheumatoid arthritis,” British Medical Bulletin, vol. 51, no. 2, pp. 419–436, 1995. View at Google Scholar · View at Scopus
  17. S. Kundu, P. Ghosh, S. Datta, A. Ghosh, S. Chattopadhyay, and M. Chatterjee, “Oxidative stress as a potential biomarker for determining disease activity in patients with rheumatoid arthritis,” Free Radical Research, vol. 46, no. 12, pp. 1482–1489, 2012. View at Google Scholar
  18. Y. Kageyama, M. Takahashi, T. Nagafusa, E. Torikai, and A. Nagano, “Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis,” Rheumatology International, vol. 28, no. 3, pp. 245–251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. L. L. Bhusate, K. E. Herbert, D. L. Scott, and D. Perrett, “Increased DNA strand breaks in mononuclear cells from patients with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 51, no. 1, pp. 8–12, 1992. View at Google Scholar · View at Scopus
  20. M. V. Williams, S. H. Lee, M. Pollack, and I. A. Blair, “Endogenous lipid hydroperoxide-mediated DNA-adduct formation in min mice,” The Journal of Biological Chemistry, vol. 281, no. 15, pp. 10127–10133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Dai, D. J. Lamb, D. S. Leake et al., “Evidence for oxidised low density lipoprotein in synovial fluid from rheumatoid arthritis patients,” Free Radical Research, vol. 32, no. 6, pp. 479–486, 2000. View at Google Scholar · View at Scopus
  22. J. D. West, C. Ji, S. T. Duncan et al., “Induction of apoptosis in colorectal carcinoma cells treated with 4-hydroxy-2-nonenal and structurally related aldehydic products of lipid peroxidation,” Chemical Research in Toxicology, vol. 17, no. 4, pp. 453–462, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. I.-Y. Yang, K. Hashimoto, N. de Wind, I. A. Blair, and M. Moriya, “Two distinct translesion synthesis pathways across a lipid peroxidation-derived DNA adduct in mammalian cells,” The Journal of Biological Chemistry, vol. 284, no. 1, pp. 191–198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. J. Picklo, A. Azenkeng, and M. R. Hoffmann, “Trans-4-oxo-2-nonenal potently alters mitochondrial function,” Free Radical Biology and Medicine, vol. 50, no. 2, pp. 400–407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. A. Doorn, S. K. Srivastava, and D. R. Petersen, “Aldose reductase catalyzes reduction of the lipid peroxidation product 4-oxonon-2-enal,” Chemical Research in Toxicology, vol. 16, no. 11, pp. 1418–1423, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Pollack, I.-Y. Yang, H. Y. Kim, I. A. Blair, and M. Moriya, “Translesion DNA synthesis across the heptanone-etheno-2′- deoxycytidine adduct in cells,” Chemical Research in Toxicology, vol. 19, no. 8, pp. 1074–1079, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Kageyama, M. Takahashi, T. Nagafusa, E. Torikai, and A. Nagano, “Methotrexate reduces the levels of pentosidine and 8-hydroxy-deoxy guanosine in patients with rheumatoid arthritis,” Modern Rheumatology, vol. 17, no. 5, pp. 398–402, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Gridley, J. K. McLaughlin, A. Ekbom et al., “Incidence of cancer among patients with rheumatoid arthritis,” Journal of the National Cancer Institute, vol. 85, no. 4, pp. 307–311, 1993. View at Google Scholar · View at Scopus
  29. L. Mellemkjær, M. S. Linet, G. Gridley, M. Frisch, H. Møller, and J. H. Olsen, “Rheumatoid arthritis and cancer risk,” European Journal of Cancer A, vol. 32, no. 10, pp. 1753–1757, 1996. View at Publisher · View at Google Scholar · View at Scopus